vs
艾伯维（ARGX）与Roper Technologies（ROP）财务数据对比。点击上方公司名可切换其他公司
艾伯维的季度营收约是Roper Technologies的1.2倍（$2.5B vs $2.1B），艾伯维净利率更高（35.5% vs 15.8%，领先19.7%），艾伯维同比增速更快（83.2% vs 11.3%），Roper Technologies自由现金流更多（$507.0M vs $322.4M）
艾伯维是总部位于美国伊利诺伊州北芝加哥的制药企业，研发生产的药物覆盖多种疾病治疗领域，可满足多元临床需求，致力于为全球不同病症的患者提供可靠的治疗方案选择。
罗珀技术公司是一家专注于科技领域的控股企业，通过持有并运营多家不同细分赛道的科技公司，在科技产业投资与资产管理领域形成了成熟的业务体系，在全球相关市场具备较高的行业影响力。
ARGX vs ROP — 直观对比
营收规模更大
ARGX
是对方的1.2倍
$2.1B
营收增速更快
ARGX
高出71.9%
11.3%
净利率更高
ARGX
高出19.7%
15.8%
自由现金流更多
ROP
多$184.6M
$322.4M
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $2.5B | $2.1B |
| 净利润 | $877.2M | $331.0M |
| 毛利率 | 89.5% | 69.4% |
| 营业利润率 | 28.9% | 27.2% |
| 净利率 | 35.5% | 15.8% |
| 营收同比 | 83.2% | 11.3% |
| 净利润同比 | 1.3% | 842.6% |
| 每股收益（稀释后） | $13.25 | $4.87 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ARGXROP
| Q1 26 | — | $2.1B | ||
| Q4 25 | $2.5B | $2.1B | ||
| Q3 25 | — | $2.0B | ||
| Q2 25 | $1.8B | $1.9B | ||
| Q1 25 | — | $1.9B | ||
| Q4 24 | $1.4B | $1.9B | ||
| Q3 24 | — | $1.8B | ||
| Q2 24 | $901.9M | $1.7B |
净利润ARGXROP
| Q1 26 | — | $331.0M | ||
| Q4 25 | $877.2M | $428.4M | ||
| Q3 25 | — | $398.5M | ||
| Q2 25 | $414.8M | $378.3M | ||
| Q1 25 | — | $331.1M | ||
| Q4 24 | $865.6M | $462.3M | ||
| Q3 24 | — | $367.9M | ||
| Q2 24 | $-32.5M | $337.1M |
毛利率ARGXROP
| Q1 26 | — | 69.4% | ||
| Q4 25 | 89.5% | 69.5% | ||
| Q3 25 | — | 69.5% | ||
| Q2 25 | 89.2% | 69.2% | ||
| Q1 25 | — | 68.7% | ||
| Q4 24 | 90.2% | 68.3% | ||
| Q3 24 | — | 69.2% | ||
| Q2 24 | 89.4% | 69.5% |
营业利润率ARGXROP
| Q1 26 | — | 27.2% | ||
| Q4 25 | 28.9% | 28.6% | ||
| Q3 25 | — | 28.4% | ||
| Q2 25 | 19.2% | 28.2% | ||
| Q1 25 | — | 27.9% | ||
| Q4 24 | 8.7% | 28.0% | ||
| Q3 24 | — | 28.1% | ||
| Q2 24 | -15.4% | 28.8% |
净利率ARGXROP
| Q1 26 | — | 15.8% | ||
| Q4 25 | 35.5% | 20.8% | ||
| Q3 25 | — | 19.8% | ||
| Q2 25 | 23.4% | 19.5% | ||
| Q1 25 | — | 17.6% | ||
| Q4 24 | 64.1% | 24.6% | ||
| Q3 24 | — | 20.8% | ||
| Q2 24 | -3.6% | 19.6% |
每股收益（稀释后）ARGXROP
| Q1 26 | — | $4.87 | ||
| Q4 25 | $13.25 | $3.97 | ||
| Q3 25 | — | $3.68 | ||
| Q2 25 | $6.32 | $3.49 | ||
| Q1 25 | — | $3.06 | ||
| Q4 24 | $13.33 | $4.29 | ||
| Q3 24 | — | $3.40 | ||
| Q2 24 | $-0.55 | $3.12 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $3.5B | $382.9M |
| 总债务越低越好 | — | $9.7B |
| 股东权益账面价值 | $7.3B | $18.8B |
| 总资产 | $8.7B | $34.6B |
| 负债/权益比越低杠杆越低 | — | 0.52× |
8季度趋势，按日历期对齐
现金及短期投资ARGXROP
| Q1 26 | — | $382.9M | ||
| Q4 25 | $3.5B | $297.4M | ||
| Q3 25 | — | $320.0M | ||
| Q2 25 | $2.1B | $242.4M | ||
| Q1 25 | — | $372.8M | ||
| Q4 24 | $1.5B | $188.2M | ||
| Q3 24 | — | $269.6M | ||
| Q2 24 | $1.4B | $251.5M |
总债务ARGXROP
| Q1 26 | — | $9.7B | ||
| Q4 25 | — | $9.3B | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $7.6B | ||
| Q3 24 | — | — | ||
| Q2 24 | $11.0M | — |
股东权益ARGXROP
| Q1 26 | — | $18.8B | ||
| Q4 25 | $7.3B | $19.9B | ||
| Q3 25 | — | $20.0B | ||
| Q2 25 | $6.1B | $19.6B | ||
| Q1 25 | — | $19.2B | ||
| Q4 24 | $5.5B | $18.9B | ||
| Q3 24 | — | $18.5B | ||
| Q2 24 | $4.3B | $18.1B |
总资产ARGXROP
| Q1 26 | — | $34.6B | ||
| Q4 25 | $8.7B | $34.6B | ||
| Q3 25 | — | $34.6B | ||
| Q2 25 | $7.2B | $33.2B | ||
| Q1 25 | — | $31.4B | ||
| Q4 24 | $6.2B | $31.3B | ||
| Q3 24 | — | $31.6B | ||
| Q2 24 | $4.8B | $29.8B |
负债/权益比ARGXROP
| Q1 26 | — | 0.52× | ||
| Q4 25 | — | 0.47× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.40× | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.00× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $323.3M | — |
| 自由现金流经营现金流 - 资本支出 | $322.4M | $507.0M |
| 自由现金流率自由现金流/营收 | 13.0% | 24.2% |
| 资本支出强度资本支出/营收 | 0.0% | 0.5% |
| 现金转化率经营现金流/净利润 | 0.37× | — |
| 过去12个月自由现金流最近4个季度 | $594.5M | — |
8季度趋势，按日历期对齐
经营现金流ARGXROP
| Q1 26 | — | — | ||
| Q4 25 | $323.3M | $738.0M | ||
| Q3 25 | — | $869.5M | ||
| Q2 25 | $361.8M | $404.1M | ||
| Q1 25 | — | $528.7M | ||
| Q4 24 | $41.9M | $722.2M | ||
| Q3 24 | — | $755.4M | ||
| Q2 24 | $-124.7M | $384.1M |
自由现金流ARGXROP
| Q1 26 | — | $507.0M | ||
| Q4 25 | $322.4M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $356.6M | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $40.9M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $-125.5M | — |
自由现金流率ARGXROP
| Q1 26 | — | 24.2% | ||
| Q4 25 | 13.0% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 20.1% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 3.0% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -13.9% | — |
资本支出强度ARGXROP
| Q1 26 | — | 0.5% | ||
| Q4 25 | 0.0% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.3% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.1% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.1% | — |
现金转化率ARGXROP
| Q1 26 | — | — | ||
| Q4 25 | 0.37× | 1.72× | ||
| Q3 25 | — | 2.18× | ||
| Q2 25 | 0.87× | 1.07× | ||
| Q1 25 | — | 1.60× | ||
| Q4 24 | 0.05× | 1.56× | ||
| Q3 24 | — | 2.05× | ||
| Q2 24 | — | 1.14× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
